4-(2-Chlorophenyl)-6-(4-chlorophenyl)-2-((2-oxo-2-phenylethyl)thio)nicotinonitrile

Catalog No. :
ACUCFF070
CAS No. :
332372-44-8
Molecular Formula :
C26H16Cl2N2OS
Molecular Weight :
475.40

IUPAC Name:4-(2-chlorophenyl)-6-(4-chlorophenyl)-2-((2-oxo-2-phenylethyl)thio)nicotinonitrile

4-(2-Chlorophenyl)-6-(4-chlorophenyl)-2-((2-oxo-2-phenylethyl)thio)nicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$271.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chlorophenyl)-6-(4-chlorophenyl)-2-((2-oxo-2-phenylethyl)thio)nicotinonitrile
IUPAC Name4-(2-chlorophenyl)-6-(4-chlorophenyl)-2-((2-oxo-2-phenylethyl)thio)nicotinonitrile
MDL No.MFCD02048640
Molecular FormulaC26H16Cl2N2OS
Molecular Weight475.40
SMILESN#CC1=C(SCC(C2=CC=CC=C2)=O)N=C(C3=CC=C(Cl)C=C3)C=C1C4=CC=CC=C4Cl
InChI KeyRZICTYOGGQXENJ-UHFFFAOYSA-N
Synonym4-(2-chlorophenyl)-6-(4-chlorophenyl)-2-phenacylsulfanylpyridine-3-carbonitrile
CAS No.332372-44-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUCFF070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNFJC293 route compound structure diagram
    ACNFJC2932462-02-4 In Stock
  4. Then
  5. ACUCFF070 route product structure diagram
    ACUCFF070332372-44-8
Inquiry

2. ACUCFF070 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNFJC293 route compound structure diagram
    ACNFJC2932462-02-4 In Stock
  4. Then
  5. ACUCFF070 route product structure diagram
    ACUCFF070332372-44-8
Inquiry

Comments (0)